What Should be the Next Vasopressor for Severe Septic Shock? Methylene Blue or Terlipressin

Clinical trial NCT03038503 · UNKNOWN

Trial details

NCT number: NCT03038503
Sponsor: Ramathibodi Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Septic Shock Refractory Shock

Start date: 2016-12-01
Primary completion: 2018-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.